BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 15081312)

  • 1. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
    Jayasankar V; Bish LT; Pirolli TJ; Berry MF; Burdick J; Woo YJ
    Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
    Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy.
    Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Berry MF; Burdick J; Bhalla RC; Sharma RV; Gardner TJ; Sweeney HL
    Circulation; 2004 Sep; 110(11 Suppl 1):II180-6. PubMed ID: 15364860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2.
    Woo YJ; Panlilio CM; Cheng RK; Liao GP; Suarez EE; Atluri P; Chaudhry HW
    J Thorac Cardiovasc Surg; 2007 Apr; 133(4):927-33. PubMed ID: 17382628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure.
    Berry MF; Pirolli TJ; Jayasankar V; Morine KJ; Moise MA; Fisher O; Gardner TJ; Patterson PH; Woo YJ
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):866-75. PubMed ID: 15573071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
    Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B
    Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.
    Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Chatterjee S; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    Circulation; 2003 Sep; 108 Suppl 1():II230-6. PubMed ID: 12970238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.
    Pleger ST; Remppis A; Heidt B; Völkers M; Chuprun JK; Kuhn M; Zhou RH; Gao E; Szabo G; Weichenhan D; Müller OJ; Eckhart AD; Katus HA; Koch WJ; Most P
    Mol Ther; 2005 Dec; 12(6):1120-9. PubMed ID: 16168714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
    Smith RS; Agata J; Xia CF; Chao L; Chao J
    Life Sci; 2005 Apr; 76(21):2457-71. PubMed ID: 15763077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
    Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL; Yin H; Huang J
    Cardiovasc Pathol; 2007; 16(4):221-30. PubMed ID: 17637430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
    Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
    J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
    Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive or maladaptive response to adenoviral adrenomedullin gene transfer is context-dependent in the heart.
    Leskinen H; Rauma-Pinola T; Szokodi I; Kerkelä R; Pikkarainen S; Uusimaa P; Hautala T; Vuolteenaho O; Ruskoaho H
    J Gene Med; 2008 Aug; 10(8):867-77. PubMed ID: 18615773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction.
    Kusano K; Tsutsumi Y; Dean J; Gavin M; Ma H; Silver M; Thorne T; Zhu Y; Losordo DW; Aikawa R
    J Mol Cell Cardiol; 2007 Feb; 42(2):390-9. PubMed ID: 17174322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
    Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
    Schalch P; Rahman GF; Patejunas G; Goldschmidt RA; Carbray J; Retuerto MA; Kim D; Esser K; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):535-40. PubMed ID: 14762365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.